Is inhibition process better described with MD(QM/MM) simulations? The case of urokinase type plasminogen activator inhibitors
2012 ◽
Vol 33
(6)
◽
pp. 607-616
◽
2002 ◽
Vol 12
(15)
◽
pp. 2023-2026
◽
1994 ◽
Vol 47
(2)
◽
pp. 195-195
2002 ◽
Vol 12
(15)
◽
pp. 2019-2022
◽
2007 ◽
Vol 50
(10)
◽
pp. 2341-2351
◽
2017 ◽
Vol 43
(2)
◽
pp. 252-257
◽
1994 ◽
Vol 170
(2)
◽
pp. 671-676
◽
1998 ◽
Vol 34
(4)
◽
pp. 566-569
◽
2005 ◽
Vol 174
(2)
◽
pp. 461-465
◽